DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Net income
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.9MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Operating cash flowDMAAR Free cash flowDMAAR Capital expendituresDMAAR Return on equityDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →